Author: Knoth H. Scriba G. K. E. Buettner B.
Publisher: Govi-Verlag
ISSN: 0031-7144
Source: Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.70, Iss.6, 2015-06, pp. : 374-378
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Arranz P. Arranz A. Moreda J.M. Cid A. Arranz J.F.
Journal of Pharmaceutical and Biomedical Analysis, Vol. 33, Iss. 4, 2003-11 ,pp. :
Posaconazole most worthy antifungal in AML
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. :
Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. :
Posaconazole: new antifungal agent promising in seriously ill patients
Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. :